product Image
[SOR] Solg™ RNase Inhibitor (Pre-made Enzyme)
Model Name
-
Series
Research Reagents (Biochemical Regent)
Data
메뉴얼-솔젠트-SOR51-E20h,_SOR51-E10k_Solg™_RNase_Inhibitor
Manufacturer information
provider logo
SOLGENT

DiaPlexQ™ Novel Coronavirus (2019-nCoV) Detection Kit, Covid19, Corona virus

Problem with product info?
Update request
Manufacturer
SOLGENT
Brand
-
SKU
125202
Product Name
[SOR] Solg™ RNase Inhibitor (Pre-made Enzyme)
Model Name
-
Size
-
Weight
-
Product Details

[SOR] Solg™ RNase Inhibitor

Recombinant ribonuclease inhibitor Inhibits common eukaryotic RNases-preventing degradation of RNA template Active over a broad pH range (pH 5 - 8)


Solg™ RNase Inhibitor is a recombinant proteins which express and purify human placenta RNase inhibitor gene in E.coli host. Generally the RNase Inhibitor inhibits ribonuclease function through formation of 1:1 complex with RNase A and it Has no effect on functions of SP6/T7/T3 RNA Polymerase , AMV/M-MLV Reverse Transcriptase or Taq DNA Polymerase. SolGent™ RNase Inhibitor shows inhibitory activity for fuction of RNase A, B and C. and it has no effect on functions of Rnase T1/T2/H/U1/U2 /CL3.




Specification

SourceHuman placenta (Recombinant)Effective pH range5.5 - 8.5



Application

cDNA synthesis, RT-PCR, In vitro transcription/translation, RNA purification & storage



Format

Product imageContentsStorage & Expiry date

Solg ™ RNase Inhibitor (40 U/㎕)1 years 6 months (In case of Store at -20 ℃ ± 5 ℃)




Ordering information

Cat. No.ProductSizePrice(won)
SOR51-E20hSolg ™ RNase Inhibitor2,000 U
(40 U/㎕)
-
SOR51-E10kSolg ™ RNase Inhibitor10,000 U
(40 U/㎕)
-





More products
SOLGENT
DiaPlexQ™ Novel Coronavirus (2019-nCoV) Detection Kit, Covid19, Corona virus
For the past 19 years, SolGent grown as a company specialized in human molecular diagnostics projects. In celebration of its 20th anniversary, the company announced its vision of a new start, “SolGent 2.0” and is growing as a bio leader in the 4th Industrial Revolution. Sturdily amassed genome analysis technology and molecular diagnostic technology have become the prominent foundation of the molecular diagnostic market, and SolGent supply products and services with the highest quality to more than 25 countries including domestic research institutes, examination centers, medical institutions and universities. In particular, as “precision medicine,” which analyzes genomes to prevent and predict diseases, becomes a new medical paradigm, SolGent develops and supplies various genome analysis services including for cancer, and expands and applies these services to agricultural products to build the AG-BIO platform. Based on its innovative technology, SolGent develops NADPH coenzyme fixed quantity measurement products DiaPlexQ™ Novel Coronavirus (2019-nCoV) Detection Kit, Covid19, Corona virus
Inquiry